Cite

HARVARD Citation

    Duffy, A. et al. (n.d.). A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. United European Gastroenterology journal. 3 (5), pp. 453-461. [Online]. 
  
Back to record